Clinical Trials Sponsored by Han Wha Pharma Co., Ltd.

Total 795 results

Sunshine Lake Pharma Co., Ltd.

Not yet recruiting

A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML

Acute Myeloid Leukemia, Adult

China
Sunshine Lake Pharma Co., Ltd.

Recruiting

Phase ll Study of HEC585 in Patients With IPF

Idiopathic Pulmonary Fibrosis

China
Sunshine Lake Pharma Co., Ltd.

Recruiting

A Clinical Trial to Evaluate Clifutinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia(AML)

Acute Myeloid Leukemia

China
Sunshine Lake Pharma Co., Ltd.

Recruiting

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Esophageal Cancer

China
Meiji Seika Pharma Co., Ltd.

Completed

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

Onychomycosis

United States
Sunshine Lake Pharma Co., Ltd.

Completed

A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

China
Sunshine Lake Pharma Co., Ltd.

Completed

ADME Study of [14C] Yiqibuvir in Healthy Male Subjects

Healthy Male Subjects

China
Guangzhou JOYO Pharma Co., Ltd

Completed

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Pulmonary Fibrosis | Diopathic Pulmonary Fibrosis

China
Guangzhou JOYO Pharma Co., Ltd

Completed

Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.

Healthy Subjects

China
Sunshine Lake Pharma Co., Ltd.

Completed

Study on the Body Mass Balance and Biotransformation of [14C]-HEC585

Healthy Volunteer

China
Sunshine Lake Pharma Co., Ltd.

Completed

HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

Healthy

China
Sunshine Lake Pharma Co., Ltd.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects

Parkinson Disease

China
Sunshine Lake Pharma Co., Ltd.

Completed

Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Hepatitis B, Chronic

China
Sunshine Lake Pharma Co., Ltd.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects

Diabetic Nephropathy

China
Sunshine Lake Pharma Co., Ltd.

Completed

Clifutinib Food Effect Study in Healthy Subjects

Acute Myeloid Leukemia in Children

China
Sunshine Lake Pharma Co., Ltd.

Completed

Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects

Type 2 Diabetes Mellitus

China
Sunshine Lake Pharma Co., Ltd.

Completed

ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects

Healthy Male Subjects

China
Sunshine Lake Pharma Co., Ltd.

Completed

To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects

Hepatic Impairment

China
Sunshine Lake Pharma Co., Ltd.

Completed

A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects

Type 2 Diabetes

China
Sunshine Lake Pharma Co., Ltd.

Completed

To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

Idiopathic Pulmonary Fibrosis

China
Sunshine Lake Pharma Co., Ltd.

Active, not recruiting

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies

Relapsed or Refractory B-cell Hematologic Malignancies

China
Taizhou EOC Pharma Co., Ltd.

Completed

Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer

Solid Tumor, Adult

China
Guangzhou JOYO Pharma Co., Ltd

Completed

Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects

Hyperlipidemia

China
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Sunshine Lake Pharma Co., Ltd.

Unknown

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects

Insomnia

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects

Non-alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

Australia
Sunshine Lake Pharma Co., Ltd.

Terminated

A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML)

China
Sunshine Lake Pharma Co., Ltd.

Completed

the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

Major Depressive Disorder

China
Sunshine Lake Pharma Co., Ltd.

Completed

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

Chronic Hepatitis C

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects

Idiopathic Pulmonary Fibrosis

United States
Nuance Pharma (shanghai) Co., Ltd

Completed

Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects

Healthy Subjects

China
Sunshine Lake Pharma Co., Ltd.

Completed

A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

Chronic Hepatitis B

China
Taizhou EOC Pharma Co., Ltd.

Unknown

Study of EOC317 in Chinese Patients With Advanced Solid Tumors

Solid Tumor

China
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

Schizophrenia

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects

Chronic Hepatitis c

China
Meiji Seika Pharma Co., Ltd.

Completed

A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595

Bacterial Infections | Healthy Volunteers

Australia
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer

Lung Cancer

China
Meiji Seika Pharma Co., Ltd.

Recruiting

Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis (Integral-1)

Acute Pyelonephritis | Complicated Urinary Tract Infection

Estonia
Sunshine Lake Pharma Co., Ltd.

Recruiting

HEC169096 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China
Sunshine Lake Pharma Co., Ltd.

Not yet recruiting

Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations

Advanced NSCLC
Sunshine Lake Pharma Co., Ltd.

Not yet recruiting

The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder

Depressive Disorder, Major
Sumitomo Pharma (Suzhou) Co., Ltd.

Terminated

Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients

First Episode Schizophrenia | Social Function | Cognition Function | Blonanserin

China
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia

Schizophrenia

China
Sunshine Lake Pharma Co., Ltd.

Suspended

Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Hepatitis B, Chronic

China
Sunshine Lake Pharma Co., Ltd.

Active, not recruiting

A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants (Z650)

Healthy Volunteers

China
Sunshine Lake Pharma Co., Ltd.

Completed

Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD

Renal Impairment

China
Sunshine Lake Pharma Co., Ltd.

Active, not recruiting

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Non-small Cell Lung Cancer

China
Sunshine Lake Pharma Co., Ltd.

Completed

A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects

Type 2 Diabetes

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects

Healthy

China
Sunshine Lake Pharma Co., Ltd.

Unknown

the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets

Insomnia

China

3

Subscribe